Back to Search
BENJAMIN RAMSEY, MD
MD
Psychiatry Physician
NPI: 1255998027Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
LL82519(SC)
CMS Specialties
PrimaryPSYCHIATRY
Education
OTHER
Class of 2019
Research & Publications (20)
Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis.
PMID 17652502·Proc Am Thorac Soc·2007
6-review
Appropriate compensation of pediatric research participants: thoughts from an Institute of Medicine committee report.
PMID 16829236·J Pediatr·2006
8-other
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
PMID 19470318·Contemp Clin Trials·2009
4-observational
Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
PMID 18822427·J Pediatr·2009
8-other
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.
PMID 18974024·J Cyst Fibros·2009
8-other
Comparing MSM in the southeastern United States who participated in an HIV prevention chat room-based outreach intervention and those who did not: how different are the baseline HIV-risk profiles?
PMID 17412716·Health Educ Res·2008
8-other
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
PMID 17534969·Pediatr Pulmonol·2007
8-other
Stigma experiences in youth with facial differences: a multi-site study of adolescents and their mothers.
PMID 17552946·Orthod Craniofac Res·2007
4-observational
Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
PMID 17763333·J Infect Dis·2007
4-observational
Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
PMID 17647287·Pediatr Pulmonol·2007
8-other
Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?
PMID 17652503·Proc Am Thorac Soc·2007
6-review
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.
PMID 17685853·Hum Gene Ther·2007
3-trial
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.
PMID 17493132·Mol Microbiol·2007
8-other
No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.
PMID 17347447·Am J Respir Cell Mol Biol·2007
4-observational
Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.
PMID 17446337·Am J Respir Crit Care Med·2007
3-trial
Advancing outcome measures for the new era of drug development in cystic fibrosis.
PMID 17652504·Proc Am Thorac Soc·2007
6-review
Association between pulmonary function and sputum biomarkers in cystic fibrosis.
PMID 17234902·Am J Respir Crit Care Med·2007
4-observational
Laboratory parameter profiles among patients with cystic fibrosis.
PMID 16829217·J Cyst Fibros·2007
4-observational
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa.
PMID 17172450·Proc Natl Acad Sci U S A·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- GENERAL PSYCHIATRY, 15 MEDICAL PAR, STE 141
COLUMBIA, SC 29203 - Phone
- (803) 434-1433
Quick Facts
- NPI
- 1255998027
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile